Sage therapeutics market cap

Author: cbke

August undefined, 2024

WebSage Therapeutics Inc market cap is $2.59B. What is the 52-week high for Sage Therapeutics Inc? 52 week high is the highest price of a stock in the past 52 weeks, or one year. Sage Therapeutics Inc 52 week high is $49.56 as of April 12, 2024. WebSage Therapeutics market cap history and chart from 2013 to 2024. Market capitalization …

Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Average …

WebFeb 25, 2024 · Market Cap Chart Since July 18, 2014, Sage Therapeutics, Inc.'s market cap … WebJan 1, 2024 · The company was formerly known as Sterogen Biopharma, Inc. and changed … jenn\u0027s wine shop

Sage Therapeutics Stock Price Today (NASDAQ: SAGE) Quote, …

WebAs of April 2024 Sage Therapeutics 's TTM earnings are -$0.54 B. companies: 7,323 total … WebDec 31, 2024 · Company profile for Sage Therapeutics Inc. including key ... S&P Mid Cap 400 -2.29%; Health Care/Life ... comprehensive quotes and volume reflect trading in all markets and are delayed at least ... WebJan 1, 2024 · The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. Tweets by Sage Therapeutics, Inc. jenn\u0027s ww tribe

SAGE - Sage Therapeutics, Inc. Stock Price and Quote - FINVIZ.com

Sage Therapeutics (SAGE) - Revenue - CompaniesMarketCap.com

WebJul 18, 2014 · SAGE Therapeutics is a neuroscience-focused company developing medicines to treat rare and orphan diseases of the central nervous system (CNS). Use the CB Insights Platform to explore SAGE Therapeutics's full profile. ... Market Cap 2.50B. Stock Price 41.78. About SAGE Therapeutics. WebView the latest Sage Therapeutics Inc. (SAGE) stock price, news, historical charts, analyst … lalaine vergara paras 2022WebMar 31, 2024 · The business's 50-day simple moving average is $43.41 and its 200 day simple moving average is $40.54. The firm has a market capitalization of $2.50 billion, a PE ratio of -4.67 and a beta of 1.15. Sage Therapeutics, Inc. has a 52-week low of $27.36 and a 52-week high of $49.56. Sage Therapeutics (NASDAQ:SAGE - Get Rating Insiders Place … jenn\u0027s ww journey youtube

"Webcompanies: 7,324 total market cap: $87.256 T. Global ranking; Ranking by countries. America 🇺🇸 United States 🇨🇦 Canada 🇲🇽 Mexico 🇧🇷 Brazil 🇨🇱 Chile. Europe ... According to Sage Therapeutics 's latest financial reports the company's total debt is $12.13 M. " - Sage therapeutics market cap

Sage therapeutics market cap

Sage Therapeutics Valuation - Simply Wall St

Web26 rows · Mar 28, 2024 · Sage Therapeutics Market Cap: 2.520B for March 28, 2024. … WebJun 25, 2024 · Sage Therapeutics, Inc. dropped from Russell Small Cap Comp Growth …

Did you know?

WebApr 6, 2024 · What is Sage Therapeutics's Market Cap? (NASDAQ: SAGE) Sage … WebAbout Market Cap. As of the previous market close, Sage Therapeutics, Inc. has a market …

WebAs Sage Therapeutics, Inc.'s (NASDAQ:SAGE) market cap increased US$122m, insiders … WebJun 25, 2024 · Sage Therapeutics, Inc. dropped from Russell Small Cap Comp Growth Index... March 2, 2024

WebSage Therapeutics and Biogen Share Update on FDA Advisory Committee for Zuranolone. … WebAs of April 2024 Sage Therapeutics has a market cap of $2.62 Billion . This makes Sage …

WebLearn to value Sage Therapeutics, Inc. (SAGE) stock with easy-to-understand analysis. ... Here we also display the market cap and forecasted growth for additional consideration. Company PB Estimated Growth Market Cap; Peer Average: 3.4x: BPMC Blueprint Medicines. 5.1x: 28.6%: US$2.6b:

jenn udoniWebOct 30, 2024 · Last week, Sage Therapeutics, Inc. ( NASDAQ: ... As Sage Therapeutics, Inc.'s (NASDAQ:SAGE) market cap increased US$122m, insiders who bought last year may be reflecting on buying more. jennum o\u0027haraWebMar 9, 2024 · Sage Therapeutics Price Performance. NASDAQ:SAGE opened at $44.42 on Thursday. The firm's 50-day moving average price is $42.89 and its 200-day moving average price is $40.21. The company has a market capitalization of $2.65 billion, a PE ratio of -4.95 and a beta of 1.15. Sage Therapeutics has a 1-year low of $27.36 and a 1-year high of … lalaine vergara paras feetWebApr 10, 2024 · Sage Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing brain health medicines. The Company's product, ZULRESSO (brexanolone) CIV injection, is for the treatment of pos tpartum depression (PPD) in adults. It has a portfolio of other product candidates with a focus on modulating two … jenn\u0027s wwWebApr 3, 2024 · Sage Therapeutics Trading Up 0.1 %. Shares of SAGE stock opened at $41.96 on Monday. Sage Therapeutics has a 12 month low of $27.36 and a 12 month high of $49.56. The stock has a market cap of $2.51 billion, a PE ratio of -4.67 and a beta of 1.15. The company's fifty day moving average price is $43.39 and its 200-day moving average … lalaine vergara-paras 2022WebOur data points out that Sage Therapeutics, Inc. (SAGE) is ranked #3480 out of 13000 companies on December - 2024. SAGE's Market Capitalization is $2.2 billion and the price per share is $37.6. Companies: 12467 Total Market Cap: $80.9T. Login. Rank by Country. America. United States (5421) Canada (682) jennuine cakesWebJan 1, 2024 · Sage Therapeutics, Inc. Market Capitalization: $2.42 Billion USD as of Jan. … jen nugent